Arcticzymes Technologies ASA
OSE:AZT

Watchlist Manager
Arcticzymes Technologies ASA Logo
Arcticzymes Technologies ASA
OSE:AZT
Watchlist
Price: 13.16 NOK -2.52%
Market Cap: 684.8m NOK
Have any thoughts about
Arcticzymes Technologies ASA?
Write Note

Operating Margin
Arcticzymes Technologies ASA

-1.4%
Current
23%
Average
-7.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1.4%
=
Operating Profit
-1.5m
/
Revenue
108.2m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
NO
Arcticzymes Technologies ASA
OSE:AZT
689.5m NOK
-1%
FR
Pharnext SCA
OTC:PNEXF
6T USD
-17 527%
US
Abbvie Inc
NYSE:ABBV
320.1B USD
28%
US
Amgen Inc
NASDAQ:AMGN
150.5B USD
19%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.4B USD
40%
US
Gilead Sciences Inc
NASDAQ:GILD
113.8B USD
38%
US
Epizyme Inc
F:EPE
94.1B EUR
-370%
AU
CSL Ltd
ASX:CSL
135.7B AUD
26%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.9B USD
30%
US
Seagen Inc
F:SGT
39.3B EUR
-33%
NL
argenx SE
XBRU:ARGX
35B EUR
-22%
Country NO
Market Cap 689.5m NOK
Operating Margin
-1%
Country FR
Market Cap 6T USD
Operating Margin
-17 527%
Country US
Market Cap 320.1B USD
Operating Margin
28%
Country US
Market Cap 150.5B USD
Operating Margin
19%
Country US
Market Cap 120.4B USD
Operating Margin
40%
Country US
Market Cap 113.8B USD
Operating Margin
38%
Country US
Market Cap 94.1B EUR
Operating Margin
-370%
Country AU
Market Cap 135.7B AUD
Operating Margin
26%
Country US
Market Cap 82.9B USD
Operating Margin
30%
Country US
Market Cap 39.3B EUR
Operating Margin
-33%
Country NL
Market Cap 35B EUR
Operating Margin
-22%
No Stocks Found

Arcticzymes Technologies ASA
Glance View

Market Cap
672.1m NOK
Industry
Biotechnology

ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms. The company went IPO on 2005-11-04. The firm focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including wound care, animal and consumer health and adjuvants.

AZT Intrinsic Value
21.99 NOK
Undervaluation 40%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-1.4%
=
Operating Profit
-1.5m
/
Revenue
108.2m
What is the Operating Margin of Arcticzymes Technologies ASA?

Based on Arcticzymes Technologies ASA's most recent financial statements, the company has Operating Margin of -1.4%.